[HTML][HTML] Clinical and microbiological outcomes and follow-up of secondary bacterial and fungal infections among critically Ill COVID-19 adult patients treated with and …
BG Szabó, E Czél, I Nagy, D Korózs, B Petrik, B Marosi… - Antibiotics, 2023 - mdpi.com
Background: Nearly 10% of COVID-19 cases will require admission to the intensive care unit
(ICU). Our aim was to assess the clinical and microbiological outcomes of secondary …
(ICU). Our aim was to assess the clinical and microbiological outcomes of secondary …
[HTML][HTML] The impact of immunosuppressive therapy on secondary infections and antimicrobial use in COVID-19 inpatients: a retrospective cohort study
P Crook, C Logan, A Mazzella, RM Wake… - BMC Infectious …, 2023 - Springer
Background Immunosuppressive therapies have become a cornerstone of the management
of severe COVID-19. The impact of these therapies on secondary infections and …
of severe COVID-19. The impact of these therapies on secondary infections and …
[HTML][HTML] Secondary infections in critically ill patients with COVID-19: a retrospective study
L Caiazzo, C Temperoni, B Canovari, O Simonetti… - Antibiotics, 2022 - mdpi.com
Patients with severe COVID-19, especially those followed in the ICU, are at risk for
developing bacterial and fungal superinfections. In this study, we aimed to describe the …
developing bacterial and fungal superinfections. In this study, we aimed to describe the …
[HTML][HTML] ICU-acquired colonization and infection related to multidrug-resistant bacteria in COVID-19 patients: a narrative review
A large proportion of ICU-acquired infections are related to multidrug-resistant bacteria
(MDR). Infections caused by these bacteria are associated with increased mortality, and …
(MDR). Infections caused by these bacteria are associated with increased mortality, and …
[HTML][HTML] Incidence of bacterial and fungal secondary infections in COVID-19 patients admitted to the ICU
AJ Alshrefy, RN Alwohaibi, SA Alhazzaa… - … Journal of General …, 2022 - ncbi.nlm.nih.gov
Purpose Secondary infections have been observed among coronavirus disease 2019
(COVID-19) patients, especially in the intensive care unit (ICU) setting, which is associated …
(COVID-19) patients, especially in the intensive care unit (ICU) setting, which is associated …
[HTML][HTML] Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship
K Rothe, S Feihl, J Schneider, F Wallnöfer… - European Journal of …, 2021 - Springer
Abstract The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Bacterial co-infections are …
syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Bacterial co-infections are …
[HTML][HTML] Bacterial and fungal co-infections and superinfections in a cohort of COVID-19 patients: real-life data from an Italian third level hospital
M Ceccarelli, A Marino, S Pulvirenti, V Coco… - Infectious Disease …, 2022 - mdpi.com
The use of immune suppressive drugs combined with the natural immune suppression
caused by SARS-CoV-2 can lead to a surge of secondary bacterial and fungal infections …
caused by SARS-CoV-2 can lead to a surge of secondary bacterial and fungal infections …
[HTML][HTML] Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired …
B Minihan, E McAuliffe, J Powell, SL Wong… - Journal of Hospital …, 2022 - Elsevier
Background Tocilizumab is an interleukin-6 inhibitor that reduces mortality and the need for
invasive mechanical ventilation, while increasing the possibility of successful hospital …
invasive mechanical ventilation, while increasing the possibility of successful hospital …
[HTML][HTML] Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
T Lingscheid, LJ Lippert, D Hillus, T Kruis, C Thibeault… - Infection, 2022 - Springer
Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …
[HTML][HTML] COVID-19-associated opportunistic infections: a snapshot on the current reports
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …
complicated challenge, especially among patients with severe disease. In recent studies …